Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
CALL
Voya Financial
VOYA
$9.17B
| $3.48M | ﹤0.01% |
59,100
+36,400
| +160% | +$1.97M |
|
4202
PUT
BJ's Restaurants
BJRI
$1.49B
| $3.47M | ﹤0.01% |
90,200
-69,600
| -44% | -$2.37M |
|
4203
Mesa Laboratories
MLAB
$573M
| $3.47M | ﹤0.01% |
12,091
+6,877
| +132% | +$1.89M |
|
|
EV
4204
DELISTED
Eaton Vance Corp.
EV
| $3.46M | ﹤0.01% |
50,953
-1,580,529
| -97% | -$98.7M |
|
4205
PUT
Brighthouse Financial
BHF
$3.48B
| $3.46M | ﹤0.01% |
95,600
-100,100
| -51% | -$3.36M |
|
4206
Yext
YEXT
$569M
| $3.46M | ﹤0.01% |
220,071
-140,330
| -39% | -$2.4M |
|
4207
PUT
Outfront Media
OUT
$5.55B
| $3.45M | ﹤0.01% |
179,421
+65,937
| +58% | +$1.11M |
|
4208
GoodRx Holdings
GDRX
$1.26B
| $3.45M | ﹤0.01% |
85,563
-17,899
| -17% | -$822K |
|
4209
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$734M
| $3.45M | ﹤0.01% |
133,910
+42,905
| +47% | +$1.08M |
|
4210
Dorman Products
DORM
$4.08B
| $3.45M | ﹤0.01% |
39,736
-49,999
| -56% | -$4.63M |
|
4211
SM Energy
SM
$7.01B
| $3.45M | ﹤0.01% |
563,508
+494,992
| +722% | +$1.67M |
|
|
CSII
4212
DELISTED
Cardiovascular Systems, Inc.
CSII
| $3.45M | ﹤0.01% |
78,812
-443,603
| -85% | -$16.7M |
|
4213
FirstService
FSV
$6.31B
| $3.45M | ﹤0.01% |
25,215
-14,666
| -37% | -$1.98M |
|
4214
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.37B
| $3.45M | ﹤0.01% |
33,770
-126,056
| -79% | -$12.9M |
|
|
KALV
4215
PUT
DELISTED
KalVista Pharmaceuticals
KALV
| $3.44M | ﹤0.01% |
+181,400
| New | +$3.11M |
|
4216
C4 Therapeutics
CCCC
$408M
| $3.44M | ﹤0.01% |
+103,873
| New | +$3.01M |
|
|
GWPH
4217
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.44M | ﹤0.01% |
29,806
-72,591
| -71% | -$8.13M |
|
|
MIC
4218
CALL
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $3.44M | ﹤0.01% |
91,500
-43,000
| -32% | -$1.32M |
|
4219
CALL
Targa Resources
TRGP
$56.3B
| $3.44M | ﹤0.01% |
130,200
+6,100
| +5% | +$130K |
|
4220
CALL
Hecla Mining
HL
$11.3B
| $3.43M | ﹤0.01% |
530,000
-44,100
| -8% | -$235K |
|
4221
Innoviva
INVA
$1.49B
| $3.43M | ﹤0.01% |
276,941
-90,151
| -25% | -$972K |
|
|
SRTA
4222
Strata Critical Medical Inc
SRTA
$519M
| $3.43M | ﹤0.01% |
+309,421
| New | +$3.16M |
|
4223
Helmerich & Payne
HP
$3.72B
| $3.43M | ﹤0.01% |
147,953
-426,151
| -74% | -$8.26M |
|
4224
Banco Santander
SAN
$210B
| $3.42M | ﹤0.01% |
1,120,349
-256,546
| -19% | -$649K |
|
4225
Pennant Group
PNTG
$1.34B
| $3.42M | ﹤0.01% |
58,842
-37,385
| -39% | -$1.8M |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.